Iron Product Choice and Dose Calculation Guide
Public consultation on the draft Iron Product Choice and Dose Calculation Guide – Adult and Paediatric and the Preoperative Bleeding Risk Assessment and Intervention Resource closed at 5pm on Thursday 20th November 2014. All submissions will be reviewed by the Clinical Writing Group before being published for download on the “Supporting Health Professionals in PBM Implementation” section of the National Blood Authority website.
Red Blood Cell and Massive Transfusion Protocol Audit Tools
Public consultation on the draft Red Blood Cell and Massive Transfusion Protocol Audit Tools closed at 5pm on Tuesday, 14th October 2014. All submissions will be reviewed by the Clinical Writing Group before being published for download and adaptation in either pdf (for print) or excel (for data collection) format to enable implementation in all institutions that perform blood transfusions.
Recognition and Management of Acute Transfusion Reactions Chart
Public consultation on the draft Recognition and Management of Acute Transfusion Reactions Chart closed at 5pm on Wednesday, 6 August 2014. All submissions will be reviewed by the Clinical Writing Group before the final chart is endorsed by the Haemovigilance Advisory Committee. The Chart was developed to standardise and improve early recognition and management of acute transfusion reactions by front line staff such as junior medical officers and nurses. The intent is to make the Chart available on the NBA website for download and adaptation in either PDF or Excel format to enable local adaption if desired.
Patient Blood Management Guidelines: Module 5 Obstetrics and Maternity
The Patient Blood Management Guidelines: Module 5 Obstetrics and Maternity was open for public consultation from 16 June 2014 – 25 July 2014. All submissions will be reviewed by the Clinical/Consumer Reference Group, which comprises representatives from specialist colleges, societies and organisations. Following that, the draft module will be submitted to the NHMRC Council for approval.
Further updates regarding the release of the Patient Blood Management Guidelines: Module 5 Obstetrics and Maternity will be provided at www.blood.gov.au/pbm-guidelines.
Imported Immunoglobulin Product Supply Contracts
Under the national blood arrangements administered by the National Blood Authority (NBA), Australia imports a range of imported Immunoglobulin (Ig) products to supplement domestic supply. The NBA last tendered for imported Immunoglobulin products in 2011. The initial term of the current Ig contracts expires on 31 December 2014.
Stakeholder Consultation Paper
The NBA issued a stakeholder consultation paper in June 2014 seeking information from stakeholders on a range of issues relevant to the Ig procurement. The purpose of this process was to inform decisions to extend current Ig contracts or conduct a Request for Tender. Responses were received from professional and representative groups and individual health care professionals. A summary of responses to the consultation paper has been prepared and is available at the links below.
- Summary of Stakeholder Consultations - Imported Immunoglobulin (pdf) (212.22 KB)
- Summary of Stakeholder Consultations - Imported Immunoglobulin (docx) (147.19 KB)
Request for Information
The NBA also issued an industry Request for Information (RFI) in June 2014, again seeking information to inform decisions to extend current Ig contracts or conduct a Request for Tender. Due to the commercial nature of the information submitted in response to the RFI a detailed summary has not been prepared.
Key points identified from the RFI process and other market intelligence are as follows:
- In general, current or potential suppliers consider that the NBA’s approach to tendering and contracting for Ig products is appropriate and sustainable
- A number of new product variants.
Outcomes of consultation
Taking into account the information obtained through consultation, together with other information available to the NBA, a decision to exercise a one year contract extension under the current contracts will be executed. Through the consultation processes the NBA has obtained a significant amount of useful feedback and information which will assist to the NBA with future Ig procurement decisions.
Decision to issue tender
Current contracts for the supply of imported immunoglobulin expire on 31 December 2015. A Request for Tender (RFT) for Imported Ig products was issued on 15 December 2014. The aim of this procurement is to establish new supply arrangements for imported IVIg and SCIg. The NBA intends to enter into contractually binding national supply arrangements for subcutaneous immunoglobulins (SCIg) to commence from as early as 1 July 2015 and intravenous immunoglobulins (IVIg) commencing from 1 January 2016.
Single Unit Transfusion Guide
The single unit transfusion guide was written in consultation with a technical writer and reviewed by a clinical cross-jurisdictional group before being available for a four-week public consultation period. The guide and supporting information is now available for health providers to adapt and download from Single Unit Transfusion Guide.